ALEXANDRIA, Va., June 19 -- United States Patent no. 12,331,115, issued on June 17, was assigned to Ose Immunotherapeutics (Nantes, France).
"Uses of anti-SIRPg antibodies" was invented by Nicolas Poirier (Treillieres, France), Caroline Mary (Sainte-Pazanne, France), Vanessa Gauttier (Reze, France), Virginie Thepenier (Sainte-Pazanne, France), Sabrina Pengam (St Luce sur Loire, France) and Bernard Vanhove (Reze, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention pertains to the field of immunotherapy. The present invention provides new uses of anti-SIRPg antibodies for the treatment and/or the prevention of autoimmune disorders or diseases."
The patent was filed on Jan. 9, 2022, under Appli...